Frequency and Geographic Distribution of Borrelia miyamotoi, Borrelia burgdorferi, and Babesia microti Infections in New England Residents.

Babesia microti Borrelia burgdorferi Borrelia miyamotoi New England seroprevalence

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
23 Mar 2022
Historique:
received: 23 11 2021
entrez: 24 3 2022
pubmed: 25 3 2022
medline: 25 3 2022
Statut: aheadofprint

Résumé

Borrelia miyamotoi is a relapsing fever spirochete that relatively recently has been reported to infect humans. It causes an acute undifferentiated febrile illness that can include meningoencephalitis and relapsing fever. Like Borrelia burgdorferi, it is transmitted by Ixodes scapularis ticks in the northeastern United States and by Ixodes pacificus ticks in the western United States. Despite reports of clinical cases from North America, Europe, and Asia, the prevalence, geographic range, and pattern of expansion of human B. miyamotoi infection are uncertain. To better understand these characteristics of B. miyamotoi in relation to other tickborne infections, we carried out a cross-sectional seroprevalence study across New England that surveyed B. miyamotoi, B. burgdorferi, and Babesia microti infections. We measured specific antibodies against B. miyamotoi, B. burgdorferi, and B. microti among individuals living in 5 New England states in 2018. Analysis of 1153 serum samples collected at 11 catchment sites showed that the average seroprevalence for B. miyamotoi was 2.8% (range, 0.6%-5.2%), which was less than that of B. burgdorferi (11.0%; range, 6.8%-15.6%) and B. microti (10.0%; range, 6.5%-13.6%). Antibody screening within county residence in New England showed varying levels of seroprevalence for these pathogens but did not reveal a vectoral geographical pattern of distribution. Human infections caused by B. miyamotoi, B. burgdorferi, and B. microti are widespread with varying prevalence throughout New England.

Sections du résumé

BACKGROUND BACKGROUND
Borrelia miyamotoi is a relapsing fever spirochete that relatively recently has been reported to infect humans. It causes an acute undifferentiated febrile illness that can include meningoencephalitis and relapsing fever. Like Borrelia burgdorferi, it is transmitted by Ixodes scapularis ticks in the northeastern United States and by Ixodes pacificus ticks in the western United States. Despite reports of clinical cases from North America, Europe, and Asia, the prevalence, geographic range, and pattern of expansion of human B. miyamotoi infection are uncertain. To better understand these characteristics of B. miyamotoi in relation to other tickborne infections, we carried out a cross-sectional seroprevalence study across New England that surveyed B. miyamotoi, B. burgdorferi, and Babesia microti infections.
METHODS METHODS
We measured specific antibodies against B. miyamotoi, B. burgdorferi, and B. microti among individuals living in 5 New England states in 2018.
RESULTS RESULTS
Analysis of 1153 serum samples collected at 11 catchment sites showed that the average seroprevalence for B. miyamotoi was 2.8% (range, 0.6%-5.2%), which was less than that of B. burgdorferi (11.0%; range, 6.8%-15.6%) and B. microti (10.0%; range, 6.5%-13.6%). Antibody screening within county residence in New England showed varying levels of seroprevalence for these pathogens but did not reveal a vectoral geographical pattern of distribution.
CONCLUSIONS CONCLUSIONS
Human infections caused by B. miyamotoi, B. burgdorferi, and B. microti are widespread with varying prevalence throughout New England.

Identifiants

pubmed: 35325084
pii: 6552230
doi: 10.1093/cid/ciac107
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : R21 AI135799
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Demerise Johnston (D)

Yale School of Public Health, Department of Epidemiology of Microbial Diseases and Yale School of Medicine, New Haven, Connecticut, USA.
US Food and Drug Administration, Laboratory of Emerging Pathogens, Silver Spring, Maryland, USA.

Jill R Kelly (JR)

Yale School of Public Health, Department of Epidemiology of Microbial Diseases and Yale School of Medicine, New Haven, Connecticut, USA.

Michel Ledizet (M)

L2 Diagnostics, New Haven, Connecticut, USA.

Nathalie Lavoie (N)

L2 Diagnostics, New Haven, Connecticut, USA.

Robert P Smith (RP)

Maine Medical Center, Portland, Maine, USA.

Jeffrey Parsonnet (J)

Mary Hitchcock Hospital, Hanover, New Hampshire, USA.

Jonathan Schwab (J)

Northampton Area Pediatrics, Northampton, Massachusetts, USA.

John Stratidis (J)

Danbury Hospital, Danbury, Connecticut, USA.

Scott Espich (S)

Yale School of Public Health, Department of Epidemiology of Microbial Diseases and Yale School of Medicine, New Haven, Connecticut, USA.

Giyoung Lee (G)

Yale School of Public Health, Department of Epidemiology of Microbial Diseases and Yale School of Medicine, New Haven, Connecticut, USA.

Kaitlin R Maciejewski (KR)

Yale School of Public Health, Department of Epidemiology of Microbial Diseases and Yale School of Medicine, New Haven, Connecticut, USA.

Yanhong Deng (Y)

Yale School of Public Health, Department of Epidemiology of Microbial Diseases and Yale School of Medicine, New Haven, Connecticut, USA.

Victoria Majam (V)

US Food and Drug Administration, Laboratory of Emerging Pathogens, Silver Spring, Maryland, USA.

Hong Zheng (H)

US Food and Drug Administration, Laboratory of Emerging Pathogens, Silver Spring, Maryland, USA.

Sougr-Nooma Bonkoungou (SN)

US Food and Drug Administration, Laboratory of Emerging Pathogens, Silver Spring, Maryland, USA.

June Stevens (J)

Yale New Haven Hospital, Department of Laboratory Medicine, New Haven, Connecticut, USA.

Sanjai Kumar (S)

US Food and Drug Administration, Laboratory of Emerging Pathogens, Silver Spring, Maryland, USA.

Peter J Krause (PJ)

Yale School of Public Health, Department of Epidemiology of Microbial Diseases and Yale School of Medicine, New Haven, Connecticut, USA.

Classifications MeSH